Ph.D. with more than 19 years of industrial experiences. Strong leadership to cross-functional CMC/process development teams in support of development of mRNA-LNP, monoclonal antibodies, enzymes, recombinant proteins from early (IND) to late and commercial stages. Experienced in phase-appropriate strategy development, budget management, and open/effective communications. Experienced in regulatory filing of IND/IMPD/BLA/MAA. Extensive people and timeline management skills.
Executive Director, Technical Development, mRNA and Protein biologics at Ultragenyx Pharmaceutical Inc.